Literature DB >> 15161628

Estrogen receptor-1 (Esr1) and -2 (Esr2) regulate the severity of clinical experimental allergic encephalomyelitis in male mice.

Magdalena Polanczyk1, Srikanth Yellayi, Alex Zamora, Sandhya Subramanian, Micah Tovey, Arthur A Vandenbark, Halina Offner, James F Zachary, Parley D Fillmore, Elizabeth P Blankenhorn, Jan-Ake Gustafsson, Cory Teuscher.   

Abstract

Estrogens and estrogen-receptor signaling function in establishing and regulating the female immune system and it is becoming increasingly evident that they may play a similar role in males. We report that B10.PL/SnJ male mice with a disrupted estrogen receptor-1 (alpha) gene (Esr1(-/-)) develop less severe clinical experimental allergic encephalomyelitis (EAE) compared to either Esr1(+/-) or wild-type (Esr1(+/+)) controls when immunized with myelin basic protein peptide Ac1-11 (MBP(Ac1-11)). In contrast, the disease course in B10.PL/SnJ male mice with a disrupted estrogen receptor-2 (beta) gene (Esr2(-/-)) does not differ from that of wild-type (Esr2(+/+)) mice. However, Esr2(+/-) mice do develop more severe clinical disease with an earlier onset indicating that heterosis at Esr2 plays a significant role in regulating EAE in males. No significant differences in central nervous system histopathology or MBP(Ac1-11)-specific T-cell responses as assessed by proliferation and interleukin-2 production were observed as a function of either Esr1 or Esr2 genotype. An analysis of cytokine/chemokine secretion by MBP(Ac1-11)-specific T cells revealed unique Esr1 and Esr2 genotype-dependent regulation. Interferon-gamma secretion was found to be negatively regulated by Esr1 whereas interleukin-6 and tumor necrosis factor-alpha secretion exhibited classical Esr2 gene dose responses. Interestingly, MCP-1 displayed distinctively unique patterns of genotype-dependent regulation by Esr1 and Esr2. The contribution of the hematopoietic and nonhematopoietic cellular compartments associated with the heterotic effect at Esr2 in regulating the severity of clinical EAE was identified using reciprocal hematopoietic radiation bone marrow chimeras generated between male wild-type and Esr2(+/-) mice. Wild-type --> Esr2(+/-) mice exhibited EAE equivalent in severity to that seen in Esr2(+/-) --> Esr2(+/-) control constructs; both of which were more severe than the clinical signs observed in Esr2(+/-) --> wild-type and wild-type --> wild-type mice. These results indicate that the heterotic effect at Esr2 is a function of the nonhematopoietic compartment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15161628      PMCID: PMC1615766          DOI: 10.1016/S0002-9440(10)63752-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  76 in total

Review 1.  Estrogen receptors: orchestrators of pleiotropic cellular responses.

Authors:  J G Moggs; G Orphanides
Journal:  EMBO Rep       Date:  2001-09       Impact factor: 8.807

Review 2.  Orphan nuclear receptors: from new ligand discovery technologies to novel signaling pathways.

Authors:  A K Shiau; P Coward; M Schwarz; J M Lehmann
Journal:  Curr Opin Drug Discov Devel       Date:  2001-09

3.  Cloning of a novel receptor expressed in rat prostate and ovary.

Authors:  G G Kuiper; E Enmark; M Pelto-Huikko; S Nilsson; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

4.  Mononuclear cell trafficking and plasma protein extravasation into the CNS during chronic relapsing experimental allergic encephalomyelitis in Biozzi AB/H mice.

Authors:  C Butter; D Baker; J K O'Neill; J L Turk
Journal:  J Neurol Sci       Date:  1991-07       Impact factor: 3.181

Review 5.  Molecular mechanism of estrogen action in the male: insights from the estrogen receptor null mice.

Authors:  J E Couse; D Mahato; E M Eddy; K S Korach
Journal:  Reprod Fertil Dev       Date:  2001       Impact factor: 2.311

6.  Myelin in multiple sclerosis is developmentally immature.

Authors:  M A Moscarello; D D Wood; C Ackerley; C Boulias
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

Review 7.  Hormonal regulation of immune responses.

Authors:  T Paavonen
Journal:  Ann Med       Date:  1994-08       Impact factor: 4.709

8.  Expression of a novel transcript of the myelin basic protein gene.

Authors:  K Kitamura; S L Newman; C W Campagnoni; J M Verdi; T Mohandas; V W Handley; A T Campagnoni
Journal:  J Neurochem       Date:  1990-06       Impact factor: 5.372

9.  Genetic analysis of disease subtypes and sexual dimorphisms in mouse experimental allergic encephalomyelitis (EAE): relapsing/remitting and monophasic remitting/nonrelapsing EAE are immunogenetically distinct.

Authors:  R J Butterfield; E P Blankenhorn; R J Roper; J F Zachary; R W Doerge; J Sudweeks; J Rose; C Teuscher
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

Review 10.  The protective effect of IFN-gamma in experimental autoimmune diseases: a central role of mycobacterial adjuvant-induced myelopoiesis.

Authors:  P Matthys; K Vermeire; H Heremans; A Billiau
Journal:  J Leukoc Biol       Date:  2000-10       Impact factor: 4.962

View more
  20 in total

1.  Oestrogen-mediated protection of experimental autoimmune encephalomyelitis in the absence of Foxp3+ regulatory T cells implicates compensatory pathways including regulatory B cells.

Authors:  Sandhya Subramanian; Melissa Yates; Arthur A Vandenbark; Halina Offner
Journal:  Immunology       Date:  2010-11-23       Impact factor: 7.397

2.  Bisphenol A (BPA) Exposure In Utero Leads to Immunoregulatory Cytokine Dysregulation in the Mouse Mammary Gland: A Potential Mechanism Programming Breast Cancer Risk.

Authors:  Catha Fischer; Ramanaiah Mamillapalli; Laura G Goetz; Elisa Jorgenson; Ysabel Ilagan; Hugh S Taylor
Journal:  Horm Cancer       Date:  2016-02-24       Impact factor: 3.869

3.  Genome-wide association study of severity in multiple sclerosis.

Authors: 
Journal:  Genes Immun       Date:  2011-06-09       Impact factor: 2.676

Review 4.  Development of subtype-selective oestrogen receptor-based therapeutics.

Authors:  Stefan Nilsson; Konrad F Koehler; Jan-Åke Gustafsson
Journal:  Nat Rev Drug Discov       Date:  2011-09-16       Impact factor: 84.694

Review 5.  Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration.

Authors:  Rory D Spence; Rhonda R Voskuhl
Journal:  Front Neuroendocrinol       Date:  2011-12-24       Impact factor: 8.606

6.  Novel feedback loop between M2 macrophages/microglia and regulatory B cells in estrogen-protected EAE mice.

Authors:  Gil Benedek; Jun Zhang; Ha Nguyen; Gail Kent; Hilary Seifert; Arthur A Vandenbark; Halina Offner
Journal:  J Neuroimmunol       Date:  2017-01-28       Impact factor: 3.478

7.  Studies in experimental autoimmune encephalomyelitis do not support developmental bisphenol a exposure as an environmental factor in increasing multiple sclerosis risk.

Authors:  Dimitry N Krementsov; Anne Katchy; Laure K Case; Frances E Carr; Barbara Davis; Cecilia Williams; Cory Teuscher
Journal:  Toxicol Sci       Date:  2013-06-23       Impact factor: 4.849

8.  Estrogen receptor-alpha as a drug target candidate for preventing lung inflammation.

Authors:  Elisabetta Vegeto; Salvatore Cuzzocrea; Concetta Crisafulli; Emanuela Mazzon; Angelo Sala; Andreè Krust; Adriana Maggi
Journal:  Endocrinology       Date:  2009-12-01       Impact factor: 4.736

9.  von-Willebrand factor influences blood brain barrier permeability and brain inflammation in experimental allergic encephalomyelitis.

Authors:  Rajkumar Noubade; Roxana del Rio; Benjamin McElvany; James F Zachary; Jason M Millward; Denisa D Wagner; Halina Offner; Elizabeth P Blankenhorn; Cory Teuscher
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

10.  G protein-coupled receptor 30-dependent protein kinase A pathway is critical in nongenomic effects of estrogen in attenuating liver injury after trauma-hemorrhage.

Authors:  Ya-Ching Hsieh; Huang-Ping Yu; Michael Frink; Takao Suzuki; Mashkoor A Choudhry; Martin G Schwacha; Irshad H Chaudry
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.